Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares iBonds Dec 2021 Term Treasury ETF (NY:IBTA)

23.16 -0.09 (-0.39%)
Streaming Delayed Price Updated: 12:25 PM EST, Dec 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iShares iBonds Dec 2021 Term Treasury ETF

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
News headline image
China-Based EV Maker Zeekr's Stock Soars Following IPO ↗
China-based Zeekr Intelligent Technology Holding received a warm welcome to Wall Street despite coming public on the same day that a report indicated that the Biden administration is preparing to... 
Via Talk Markets
Topics World Trade
News headline image
Ibotta Appoints Stephen Bailey to Board of Directors and Shalin Patel as new Head of Investor Relations
From Ibotta
Via GlobeNewswire
News headline image
Ibotta To Announce First Quarter 2024 Financial Results on May 30, 2024
From Ibotta
Via GlobeNewswire
News headline image
Ibotta Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering
From Ibotta
Via GlobeNewswire
News headline image
Ibotta Soars In Strong Market Debut ↗
Shares of Walmart-backed Ibotta soared in their market debut, rising more than 30% and giving the digital marketing company a valuation of about $3.55 billion. 
Via Talk Markets
News headline image
IBTA Stock IPO: 7 Things to Know as Ibotta Starts Trading Today ↗
Here's what to know about the IBTA stock IPO, as Ibotta climbs on its opening day of trading on the Nasdaq exchange today. 
Via InvestorPlace
Topics Initial Public Offering
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.